Advanced Search
Current and Breaking News for Professionals, Consumers and Media

Click here to learn how to advertise on this site and for ad rates.

Disease Author: FDA Consumer Health Information Last Updated: Apr 10, 2014 - 11:32:29 AM

Irritable Bowel Syndrome Treatments Aren’t One-Size-Fits-All

By FDA Consumer Health Information
Apr 10, 2014 - 11:28:59 AM

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Ezine
For Email Marketing you can trust

Email this article
 Printer friendly page

( - Irritable bowel syndrome (IBS) is an often misunderstood and underdiagnosed condition that affects about 15.3 million people in the United States. No one remedy works for all patients, so the Food and Drug Administration (FDA) is working to bring more treatments to the market

Read the Consumer Update to learn more.

FDA Consumer Updates may be posted and published elsewhere without permission. Please credit "FDA Consumer Health Information" as the source. FDA values feedback on its consumer health information. Send questions, comments or story ideas to: [email protected].


For advertising or promotion on, call Mike McCurdy at: 877-634-9180. We have over 7,000 journalists as subscribers and may use our content


Top of Page

Latest Headlines

+ Targeted Therapies for Inflammatory Bowel diseases
+ Detecting Early Signs of Sepsis
+ Understanding Rheumatic Diseases
+ Using Copper to Prevent the Spread of Respiratory Viruses
+ Multistate Foodborne Disease Outbreaks Sicken Thousands
+ World Psoriasis Day Gives Hope to People with Psoriasis
+ Health Care Costs for Dementia Found Greater Than for Any Other Disease
+ Inflammation in the Brain Is Linked to Risk of Schizophrenia
+ Discover Possible One-pill Cure for Malaria
+ Speed Into Battle Against Parkinsons

Contact Us | Job Listings | Help | Site Map | About Us
Advertising Information | HND Press Release | Submit Information | Disclaimer

Site hosted by Sanchez Productions